Image Solutions, Inc. (ISI)'s SaaS Approach to eCTD Submissions Helps Boehringer Ingelheim Corporation Meet FDA Submission Requirements in Record Time

ESCHBORN, Germany--(BUSINESS WIRE)--Image Solutions, Inc. (ISI), a leading provider of software and services to streamline the drug development and regulatory approval process, today announced that world-leading global pharmaceutical group Boehringer Ingelheim has deployed eCTDXPress – the company’s flagship solution for managing and reviewing electronic submissions – via a Software-as-a-Service (SaaS) hosted model. The process from selection to implementation and validation took just under eight months.